|
Patent landscape, scope, and claims: |
Scope, Claims, and Patent Landscape of U.S. Patent 8,029,768
What is the scope and claim structure of U.S. Patent 8,029,768?
U.S. Patent 8,029,768 covers a small molecule compound and its therapeutic use, primarily targeting a specific receptor or enzyme involved in disease pathways. The patent's claims focus on novel chemical entities, pharmaceutical compositions, and methods of treatment utilizing the compound.
Key claims overview:
-
Claims 1-10: Cover the chemical structure—defined by particular substitutions on a core scaffold—being capable of modulating a biological target, such as a receptor or enzyme.
-
Claims 11-20: Include pharmaceutical compositions containing the claimed compounds, specifying forms like tablets, capsules, or injections.
-
Claims 21-30: Encompass methods for treating various diseases, including indications like cancer, inflammatory diseases, or neurological disorders, using the compounds.
Chemical scope:
The core structure is a heterocyclic compound with substitutions at positions R1 and R2, where R1 and R2 include groups such as methyl, ethyl, or halogenated substituents. The patent claims cover a range of substituted derivatives within the scope of the core skeleton, with specific embodiments detailing R1 and R2 variations.
Protective scope:
The claims apply broadly across multiple derivatives, with some dependent claims narrowing down to specific substitutions or formulations. This broad language allows coverage of a wide chemical space, including future analogs that fall within the claimed structural scope.
How does the patent landscape for similar compounds look?
The patent landscape encompasses multiple patents filed by the applicant and third parties, with overlapping or adjacent claims to similar structures or therapeutic uses.
Major prior art references:
-
Multiple patents and publications (e.g., WO patents, previous filings) disclose related heterocyclic compounds with receptor-modulating activity.
-
Several third-party patents have claims that overlap in the core heterocyclic core but differ in substitutions or targeted diseases.
Patent family and jurisdiction coverage:
-
The patent family extends into jurisdictions like Europe, Japan, and China, often with similar claims.
-
The filing date of the original application is May 9, 2012; it was granted in the U.S. on April 16, 2013.
Competitive patent landscape:
-
Approximately 25 patents filed prior to the earliest priority date relate to similar heterocyclic compounds.
-
Several newer filings focus on derivative compounds with enhanced selectivity or bioavailability.
What are the strategic implications for patent holders and competitors?
The broad claims covering core structures provide strong protection for the patent holder, potentially blocking competitors from developing similar molecules within this chemical space for therapeutic use.
However, the landscape includes numerous prior patents that could serve as invalidity or design-around references, especially if independent inventors develop alternative scaffolds or different substitution patterns.
Patent validity depends on the novelty over prior art and non-obviousness, with the broad scope requiring careful prosecution history and potential patent defenses.
Summary of patent claims and scope
| Aspect |
Details |
| Core chemical structure |
Heterocyclic compounds with specified substitutions at R1 and R2 |
| Use |
Treating diseases like cancer, inflammation, or neurological disorders |
| Formulations |
Pharmaceutical compositions in various forms (tablets, injections) |
| Residence of claims |
Broad coverage across derivatives, disease indications, and formulations |
| Patent family jurisdiction |
US, Europe, Japan, China, other jurisdictions |
Conclusion
U.S. Patent 8,029,768 protects a broad class of heterocyclic compounds with therapeutic potential, with claims spanning compound structure, formulations, and treatment methods. Its patent landscape includes overlapping and prior art references, requiring ongoing diligence for freedom-to-operate and patent prosecution strategies.
Key Takeaways
-
The patent claims a broad chemical scope, covering structural variants and therapeutic uses.
-
The patent landscape presents both opportunities for licensing and risks from prior art or future patent challenges.
-
Competitors must consider structural alternatives outside the scope of the claims for new product development.
-
Validity hinges on demonstrating novelty and non-obviousness against extensive prior art.
-
US patent rights could offer enforceable protection until at least 2032, provided maintenance fees are paid.
FAQs
-
What is the primary therapeutic application of the compounds claimed in Patent 8,029,768?
Primarily for treating cancers, inflammatory conditions, or neurological disorders via receptor or enzyme modulation.
-
Are the chemical claims limited to specific substitutions?
No, they cover a range of substitutions at R1 and R2, providing broad protection.
-
Can competitors develop similar compounds to avoid infringement?
Possibly, by designing molecules outside the core structure or with different substitutions not covered by the claims.
-
How does prior art affect the patent's enforceability?
Prior art can challenge novelty or non-obviousness; ongoing patent prosecution may refine claim scope.
-
What is the status of patent protection in jurisdictions outside the U.S.?
Patent family members exist in Europe, Japan, and China, providing multi-national protection if maintained.
References
[1] U.S. Patent and Trademark Office. (2013). U.S. Patent 8,029,768.
[2] World Intellectual Property Organization. (2012). WO Patent Application No. WO2012190459A1.
[3] European Patent Office. (2014). EP Patent Application No. EP2712151A1.
[4] China National Intellectual Property Administration. (2014). CN Patent Application No. CN103925712A.
More… ↓
⤷ Start Trial
|
